The prognostic impact of peritoneal washing cytology for otherwise resectable extrahepatic cholangiocarcinoma patients

[1]  T. Fujii,et al.  Prognostic importance of peritoneal washing cytology in patients with otherwise resectable pancreatic ductal adenocarcinoma who underwent pancreatectomy: A nationwide, cancer registry-based study from the Japan Pancreas Society. , 2019, Surgery.

[2]  J. Raftery,et al.  Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. , 2019, The Lancet. Oncology.

[3]  K. Ohta,et al.  Prognostic factors for cytology-positive gastric cancer , 2018, Surgery Today.

[4]  M. Ando,et al.  Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer , 2018, The British journal of surgery.

[5]  G. Gores,et al.  Cholangiocarcinoma — evolving concepts and therapeutic strategies , 2018, Nature Reviews Clinical Oncology.

[6]  R. Higuchi,et al.  ENBD is Associated with Decreased Tumor Dissemination Compared to PTBD in Perihilar Cholangiocarcinoma , 2017, Journal of Gastrointestinal Surgery.

[7]  M. Nagino,et al.  Percutaneous biliary drainage is oncologically inferior to endoscopic drainage: a propensity score matching analysis in resectable distal cholangiocarcinoma , 2016, Journal of Gastroenterology.

[8]  J. K. Lee,et al.  A Comparison of Preoperative Biliary Drainage Methods for Perihilar Cholangiocarcinoma: Endoscopic versus Percutaneous Transhepatic Biliary Drainage , 2015, Gut and liver.

[9]  G. Honda,et al.  Impact of Preoperative Biliary Drainage on Long-Term Survival in Resected Pancreatic Ductal Adenocarcinoma: A Multicenter Observational Study , 2015, Annals of Surgical Oncology.

[10]  C. Verbeke,et al.  Impact of intrapancreatic or extrapancreatic bile duct involvement on survival following pancreatoduodenectomy for common bile duct cancer , 2014, The British journal of surgery.

[11]  Jaime Prat,et al.  Staging classification for cancer of the ovary, fallopian tube, and peritoneum , 2014, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[12]  Y. Murakami,et al.  Perineural Invasion in Extrahepatic Cholangiocarcinoma: Prognostic Impact and Treatment Strategies , 2013, Journal of Gastrointestinal Surgery.

[13]  G. Ko,et al.  Solitary percutaneous transhepatic biliary drainage tract metastasis after curative resection of perihilar cholangiocarcinoma: report of a case , 2011, Korean journal of hepato-biliary-pancreatic surgery.

[14]  M. Asaka,et al.  Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma , 2011, Journal of Gastroenterology.

[15]  D. Cunningham,et al.  Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. , 2010, The New England journal of medicine.

[16]  K. Hatakeyama,et al.  Depth of invasion determines the postresectional prognosis for patients with T1 extrahepatic cholangiocarcinoma , 2010, Cancer.

[17]  Y. Murakami,et al.  Adjuvant Gemcitabine Plus S-1 Chemotherapy Improves Survival After Aggressive Surgical Resection for Advanced Biliary Carcinoma , 2009, Annals of surgery.

[18]  D. Coit,et al.  The influence of positive peritoneal cytology on survival in patients with pancreatic adenocarcinoma , 2006, Journal of Gastrointestinal Surgery.

[19]  M. Makuuchi,et al.  Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radial margins. , 2005, Surgery.

[20]  Jin‐Young Jang,et al.  Actual Long-term Outcome of Extrahepatic Bile Duct Cancer After Surgical Resection , 2005, Annals of surgery.

[21]  H. Thomas,et al.  Changing international trends in mortality rates for liver, biliary and pancreatic tumours. , 2002, Journal of hepatology.

[22]  W. Jarnagin,et al.  Peritoneal washings are not predictive of occult peritoneal disease in patients with hilar cholangiocarcinoma. , 2001, Journal of the American College of Surgeons.

[23]  M. Gonen,et al.  Staging, Resectability, and Outcome in 225 Patients With Hilar Cholangiocarcinoma , 2001, Annals of surgery.

[24]  H. Thomas,et al.  Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968–1998 , 2001, Gut.

[25]  S. Schwartz,et al.  Surgical treatment and outcomes in carcinoma of the extrahepatic bile ducts: the University of Rochester experience. , 2001, Archives of surgery.

[26]  J. Figueras,et al.  Biliary tract cancers. , 2000, The New England journal of medicine.

[27]  G. Gores,et al.  Biliary tract cancers. , 1999, The New England journal of medicine.

[28]  J. Cooper.  Ajcc Cancer Staging Manual , 1997 .

[29]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.